In the News | Friends of Cancer Research

You are here

In the News

February 11, 2019
Executive Summary Emerging standards for regulatory use of RWE should resist the temptation to impose the standards and expectations of randomized clinical trials to a fundamentally different kind of... Read more
February 8, 2019
Washington DC - Friends of Cancer Research (Friends) joins the nation in mourning the loss of former Democratic Representative John Dingell of Michigan. "For decades, the country counted on the... Read more
February 8, 2019
A notable benefit of using wearable devices and other innovative technology to collect patient data in real-time is to encourage the design and implementation of clinical trials conducted at the... Read more
February 5, 2019
Cancer in adolescents and young adults Her untimely death has once again shone a light on a global subgroup of 1 million cancer patients, referred to as adolescents and young adults (AYA), who, as of... Read more
February 1, 2019
The Lung Cancer Master Protocol (Lung-MAP), the first precision medicine trial in lung cancer supported by the National Cancer Institute (NCI), is undergoing a major expansion to include patients... Read more
February 1, 2019
The Lung Cancer Master Protocol is undergoing a major expansion to include patients with all non-small cell lung cancers.   The trial previously tested treatments for people with advanced stage... Read more
February 1, 2019
Easing comorbid-condition exclusion criteria could significantly increase participation in clinical trials for cancer, researchers report.   "Some eligibility exclusions for comorbid conditions will... Read more
February 1, 2019
FDA is enhancing its ability to handle real-world evidence by training reviewers in data science via a curriculum on machine learning and artificial intelligence, said FDA Commissioner Scott Gottlieb... Read more
January 31, 2019
A pair of former FDA commissioners debated whether FDA should take the lead on using real-world data and real-world evidence to determine the actual value of drug therapies and in turn ensure the... Read more
January 29, 2019
Stressing the need for speed and efficiency, FDA Commissioner Scott Gottlieb on Monday offered a look at FDA’s plans around real-world data (RWD) and real-world evidence (RWE) in 2019.   The speech... Read more

Pages